Myoblox Contra Capsules 56ct Bottle
Recalling firm: NutraCap Labs LLC
During an FDA investigation the firm was notified that the product contains undeclared milk.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: May 21, 2024.
Check your package
Compare the exact product and package details with the label you have.
850001912303FDA code information
LOT #2110060 EXP DATE 10/2023 LOT #2108169 EXP DATE 08/2023
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 850001912303 | Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3 |
| lot | 2108169 | LOT #2110060 EXP DATE 10/2023 LOT #2108169 EXP DATE 08/2023 |
| lot | 2110060 | LOT #2110060 EXP DATE 10/2023 LOT #2108169 EXP DATE 08/2023 |
Original FDA recall reason
During an FDA investigation the firm was notified that the product contains undeclared milk.
Recall details
- Recall number
- F-0467-2022
- Event ID
- 89000
- FDA status
- Terminated
- Initiated
- Nov 9, 2021
- Reported
- Jan 19, 2022
- Classified
- Jan 11, 2022
- Terminated
- May 21, 2024
- Quantity
- 80,169 various bottles and jars
- Location
- Norcross, GA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, LA, MD, MN, NC, NJ, NV, NY, OH, OR, SC, TN, TX, VA & WA.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.